Literature DB >> 7031157

Hemorheology and peripheral vascular diseases: a new therapeutic approach.

R Müller.   

Abstract

New findings on the physiology of flow properties of blood are reviewed. Particular attention is paid to hemorheologic occurrences in the decompensated microcirculation in peripheral vascular disease. The therapeutic possibilities for obtaining functional compensation are discussed. Trental (pentoxifylline) largely satisfies the complex requirements of a hemorheologically active therapeutic agent.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7031157

Source DB:  PubMed          Journal:  J Med        ISSN： 0025-7850


  10 in total

Review 1.  The clinical importance of erythrocyte deformability, a hemorrheological parameter.

Authors:  F C Mokken; M Kedaria; C P Henny; M R Hardeman; A W Gelb
Journal:  Ann Hematol       Date:  1992-03       Impact factor: 3.673

Review 2.  Pharmacology of nootropics and metabolically active compounds in relation to their use in dementia.

Authors:  C D Nicholson
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

3.  The effect of pentoxifylline on oxidative stress in CO2 pneumoperitoneum.

Authors:  Ayhan Dinckan; Emel Sahin; Mehmet Ogus; Kemal Emek; Saadet Gumuslu
Journal:  Surg Endosc       Date:  2008-03-18       Impact factor: 4.584

Review 4.  Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy.

Authors:  A Ward; S P Clissold
Journal:  Drugs       Date:  1987-07       Impact factor: 9.546

5.  Pentoxifylline therapy: a new adjunct in the treatment of pulmonary hypertension?

Authors:  I S Park; R D Leachman
Journal:  Tex Heart Inst J       Date:  1988

6.  Therapeutic potentials of pentoxifylline for treatment of cardiovascular diseases.

Authors:  Ming Zhang; Yan-Jun Xu; Shushma A Mengi; Amarjit S Arneja; Naranjan S Dhalla
Journal:  Exp Clin Cardiol       Date:  2004

Review 7.  Buflomedil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in peripheral and cerebral vascular diseases.

Authors:  S P Clissold; S Lynch; E M Sorkin
Journal:  Drugs       Date:  1987-05       Impact factor: 9.546

8.  The effect of denbufylline on the viscosity of rat whole blood and on the deformability (filterability) of rat blood cell suspensions.

Authors:  J J Jukna; C D Nicholson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-04       Impact factor: 3.000

9.  Treatment of homozygous sickle cell disease with pentoxifylline.

Authors:  A Sacerdote
Journal:  J Natl Med Assoc       Date:  1999-08       Impact factor: 1.798

10.  Changes in tumour blood flow, oxygenation and interstitial fluid pressure induced by pentoxifylline.

Authors:  I Lee; Y Boucher; T J Demhartner; R K Jain
Journal:  Br J Cancer       Date:  1994-03       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.